SCHEMBL6016770

SCHEMBL6016770

Cc1cc(Nc2ncc(F)c(Nc3ccc4c(c3)NC=CO4)n2)cc(F)c1O

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AURKA O14965 6/20 0.47
SYK P43405 15/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654924 0.92 SYK (0.53) AURKASYK
SCHEMBL655141 0.84 SYK (0.67) AURKASYK
SCHEMBL657172 0.84 SYK (0.67) AURKASYK
SCHEMBL655682 0.83 SYK (0.65) AURKASYK
SCHEMBL657427 0.81 SYK (0.66) AURKASYK
SCHEMBL655490 0.80 SYK (0.52) AURKASYK
SCHEMBL656586 0.79 SYK (0.67) AURKASYK
SCHEMBL15252772 0.76 SYK (0.49) AURKASYK
SCHEMBL657430 0.76 SYK (0.67) AURKASYK
SCHEMBL658530 0.76 SYK (0.67) AURKASYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed